Glial tumors have demonstrated abilities to sustain growth recruitment of glial progenitor cells (GPCs), which is believed to be driven by chemotactic cues. Previous studies have illustrated that mouse GPCs of different genetic backgrounds are able to replicate the dispersion pattern seen in the human disease. How GPCs with genetic backgrounds transformed by tumor paracrine signaling respond to extracellular cues migration is largely unexplored, and remains a limiting factor in utilizing GPCs as therapeutic targets.
View Article and Find Full Text PDF